Organigram (TSE:OGI) Director Sells C$33,347.94 in Stock

Key Points

• Director Donald Geoffrey Machum sold roughly 76,647 Organigram shares on March 25–26 for about C$143,000, reducing his stake by ~94% to just 1,125 shares valued at C$2,092.50.
• OGI traded at C$1.74 (down C$0.07) with a market cap around C$237M, a P/E of 11.3, and the share price sitting below both the 50‑day and 200‑day moving averages on below‑average volume.
• Analyst consensus remains a "Buy" with a consensus price target of C$3.13, although some firms have recently trimmed ratings and targets.

Organigram Holdings Inc. (TSE:OGI - Get Free Report) Director Donald Geoffrey Machum sold 17,929 shares of Organigram stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of C$1.86, for a total value of C$33,347.94. Following the transaction, the director owned 1,125 shares of the company's stock, valued at C$2,092.50. The trade was a 94.10% decrease in their position.

Donald Geoffrey Machum also recently made the following trade(s):

• On Wednesday, March 25th, Donald Geoffrey Machum sold 10,700 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$20,009.00.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 12,400 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$23,188.00.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 10,471 shares of Organigram stock. The stock was sold at an average price of C$1.86, for a total value of C$19,476.06.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 3,700 shares of Organigram stock. The stock was sold at an average price of C$1.87, for a total value of C$6,919.00.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 17,347 shares of Organigram stock. The shares were sold at an average price of C$1.85, for a total value of C$32,091.95.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 500 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$935.00.
• On Wednesday, March 25th, Donald Geoffrey Machum sold 600 shares of Organigram stock. The shares were sold at an average price of C$1.85, for a total value of C$1,110.00.
• On Thursday, March 26th, Donald Geoffrey Machum sold 700 shares of Organigram stock. The shares were sold at an average price of C$1.88, for a total transaction of C$1,316.00.
• On Thursday, March 26th, Donald Geoffrey Machum sold 100 shares of Organigram stock. The stock was sold at an average price of C$1.86, for a total transaction of C$186.00.
• On Thursday, March 26th, Donald Geoffrey Machum sold 400 shares of Organigram stock. The stock was sold at an average price of C$1.89, for a total transaction of C$756.00.

Organigram Stock Performance

OGI traded down C$0.07 on Monday, reaching C$1.74. The company had a trading volume of 74,982 shares, compared to its average volume of 233,742. The stock has a market cap of C$237.23 million, a P/E ratio of 11.30, a P/E/G ratio of 0.42 and a beta of 1.81. The company has a debt-to-equity ratio of 2.29, a quick ratio of 2.62 and a current ratio of 2.73. Organigram Holdings Inc. has a fifty-two week low of C$1.22 and a fifty-two week high of C$3.09. The company's fifty day moving average is C$1.98 and its 200 day moving average is C$2.25.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Canaccord Genuity Group set a C$3.00 price target on Organigram and gave the stock a "buy" rating in a report on Tuesday, January 27th. ATB Cormark Capital Markets cut Organigram from a "strong-buy" rating to a "moderate buy" rating and lowered their price objective for the stock from C$3.50 to C$3.25 in a research report on Wednesday, February 11th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Organigram has a consensus rating of "Buy" and a consensus price target of C$3.13.

Organigram News Roundup

Here are the key news stories impacting Organigram this week:

• Neutral Sentiment: Lower intraday liquidity and technicals: volume is below the stock's average, and the share price sits under both the 50-day (C$1.98) and 200-day (C$2.25) moving averages, which can amplify downward moves.
• Neutral Sentiment: Company size and valuation context: market cap ≈ C$240M with a P/E ≈ 11.4 and PEG ≈ 0.42 — valuation metrics that may limit downside for some value-oriented buyers but are not a strong near-term demand driver.
• Negative Sentiment: Significant director selling disclosed (Mar 25–26): Director Donald Geoffrey Machum sold a total of approximately 76,647 OGI shares across multiple filings for roughly C$143k in proceeds, leaving him with 1,125 shares (substantially reduced ownership). Insider sales at scale often weigh on sentiment and can prompt short-term selling pressure. MarketBeat filings

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.